pharma · Hepatocellular Carcinoma · Obesity
Hospital Authority
Hospital Authority, Hong Kong
Hospital Authority clinical programs — 322 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Hospital Authority Building, 147B Argyle Street, Kowloon, Hong Kong, 852, HK, CN
- Founded
- 1991
- Employees
- 12,669
- Programs
- 322
- Drugs
- 301
- Patents
- 0
Hospital Authority projects
322 ClinicalTrials.gov programs sponsored by Hospital Authority.
Hospital Authority has 322 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Polyethylene glycol (PEG)
Hospital Authority, Hong Kong
Acute Kidney Injury
1 trial -
Progesterone
Hospital Authority, Hong Kong
Preterm
1 trial -
Propofol
Hospital Authority, Hong Kong
Renal Cell Carcinoma
1 trial -
Protein supplementation
Hospital Authority, Hong Kong
Hip Fractures
1 trial -
Rabeprazole 20mg twice daily
Hospital Authority, Hong Kong
Chest Pain
1 trial -
Remimazolam_OPCAB
Hospital Authority, Hong Kong
Hemodynamic Instability
1 trial -
Ropivacaine
Hospital Authority, Hong Kong
Liver Diseases
1 trial -
Ropivacaine
Hospital Authority, Hong Kong
Femoral Fracture
1 trial -
SBRT
Hospital Authority, Hong Kong
Spine Metastases
1 trial -
Screening only
Hospital Authority, Hong Kong
Panic Attacks and Disorders
1 trial -
Short course palliative radiation.
Hospital Authority, Hong Kong
Cervical Cancer
1 trial -
Sniffing emotional tears
Hospital Authority, Hong Kong
Obesity
1 trial -
Standard Dose Spirulina Platensis
Hospital Authority, Hong Kong
HBV Carrier
1 trial -
Statin
Hospital Authority, Hong Kong
HCC
1 trial -
Tadalafil 2.5Mg Tab
Hospital Authority, Hong Kong
Erectile Dysfunction
1 trial -
Tailored AI echocardiogram analysis and reporting system
Hospital Authority, Hong Kong
Heart Failure
1 trial -
Terbutaline
Hospital Authority, Hong Kong
Nonreassuring Fetal Status
1 trial -
Tranexamic Acid 100Mg/Ml Inj Vil 10Ml
Hospital Authority, Hong Kong
Rotator Cuff Tears
1 trial -
Ultra low dose chest computed tomography (ULDCT)
Hospital Authority, Hong Kong
Tuberculosis, Pulmonary
1 trial -
Umbilical cord serum eyedrops
Hospital Authority, Hong Kong
Recurrent Corneal Erosion
1 trial -
Vaginal progesterone
Hospital Authority, Hong Kong
Preterm Birth
1 trial -
Vitamin D3
Hospital Authority, Hong Kong
Overweight and Obesity
1 trial -
Vitamin D3
Hospital Authority, Hong Kong
Major Depression
1 trial -
adefovir dipivoxil
Hospital Authority, Hong Kong
Hepatitis B
1 trial -
atosiban
Hospital Authority, Hong Kong
Repeated Implantation Failure
1 trial -
fentanyl
Hospital Authority, Hong Kong
Anesthesia, Spinal
1 trial -
metformin, topiramate
Hospital Authority, Hong Kong
Obesity
1 trial -
morphine
Hospital Authority, Hong Kong
Pain Postoperative
1 trial -
oral nutritional supplement
Hospital Authority, Hong Kong
Gastric Cancer
1 trial -
plasmalyte solution
Hospital Authority, Hong Kong
Cardiac Surgery
1 trial -
probiotic cocktail capsules
Hospital Authority, Hong Kong
Vancomycin-Resistant Enterococci
1 trial -
probiotics
Hospital Authority, Hong Kong
Parkinson's Disease (PD)
1 trial -
rabeprazole plus aspirin versus rabeprazole plus clopidogrel
Hospital Authority, Hong Kong
Gastric Ulcer
1 trial -
warfarin
Hospital Authority, Hong Kong
Deep Venous Thromboembolism
1 trial
Frequently asked questions
How many clinical projects does Hospital Authority have?
322 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.